Literature DB >> 27043975

New perspectives on the role of cardiac magnetic resonance imaging to evaluate myocardial salvage and myocardial hemorrhage after acute reperfused ST-elevation myocardial infarction.

Kenneth Mangion1,2, David Corcoran1,2, David Carrick1,2, Colin Berry1,2.   

Abstract

Cardiac magnetic resonance (CMR) imaging enables the assessment of left ventricular function and pathology. In addition to established contrast-enhanced methods for the assessment of infarct size and microvascular obstruction, other infarct pathologies, such as myocardial edema and myocardial hemorrhage, can be identified using innovative CMR techniques. The initial extent of myocardial edema revealed by T2-weighted CMR has to be stable for edema to be taken as a retrospective marker of the area-at-risk, which is used to calculate myocardial salvage. The timing of edema assessment is important and should be focused within 2 - 7 days post-reperfusion. Some recent investigations have called into question the diagnostic validity of edema imaging after acute STEMI. Considering the results of these studies, as well as results from our own laboratory, we conclude that the time-course of edema post-STEMI is unimodal, not bimodal. Myocardial hemorrhage is the final consequence of severe vascular injury and a progressive and prognostically important complication early post-MI. Myocardial hemorrhage is a therapeutic target to limit reperfusion injury and infarct size post-STEMI.

Entities:  

Keywords:  ST-elevation myocardial infarction; magnetic resonance imaging; microvascular dysfunction; myocardial hemorrhage; prognosis; remodeling

Mesh:

Substances:

Year:  2016        PMID: 27043975     DOI: 10.1586/14779072.2016.1173544

Source DB:  PubMed          Journal:  Expert Rev Cardiovasc Ther        ISSN: 1477-9072


  3 in total

1.  Comparative Prognostic Utility of Indexes of Microvascular Function Alone or in Combination in Patients With an Acute ST-Segment-Elevation Myocardial Infarction.

Authors:  David Carrick; Caroline Haig; Nadeem Ahmed; Jaclyn Carberry; Vannesa Teng Yue May; Margaret McEntegart; Mark C Petrie; Hany Eteiba; Mitchell Lindsay; Stuart Hood; Stuart Watkins; Andrew Davie; Ahmed Mahrous; Ify Mordi; Ian Ford; Aleksandra Radjenovic; Keith G Oldroyd; Colin Berry
Journal:  Circulation       Date:  2016-11-01       Impact factor: 29.690

Review 2.  Characterizing Cardiac Involvement in Chronic Kidney Disease Using CMR-a Systematic Review.

Authors:  Kenneth Mangion; Kirsty McDowell; Patrick B Mark; Elaine Rutherford
Journal:  Curr Cardiovasc Imaging Rep       Date:  2018-01-31

Review 3.  Society for Cardiovascular Magnetic Resonance (SCMR) expert consensus for CMR imaging endpoints in clinical research: part I - analytical validation and clinical qualification.

Authors:  Valentina O Puntmann; Silvia Valbuena; Rocio Hinojar; Steffen E Petersen; John P Greenwood; Christopher M Kramer; Raymond Y Kwong; Gerry P McCann; Colin Berry; Eike Nagel
Journal:  J Cardiovasc Magn Reson       Date:  2018-09-20       Impact factor: 5.364

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.